Feb 19 (Reuters) - Warren Buffett's Berkshire Hathaway BRKa.N said it sold 750,000 shares of DaVita DVA.N between February 14 and 19, reducing its stake in the kidney dialysis services provider by about 2% to 35.14 million shares.
Berkshire disclosed the sales in a Wednesday night filing with the U.S. Securities and Exchange Commission. The selling followed Berkshire's sale of 203,091 DaVita shares on February 11.
(Reporting by Jonathan Stempel in New York; Editing by Sandra Maler)
((jon.stempel@thomsonreuters.com; +1 646 223 6317; Reuters Messaging: jon.stempel.thomsonreuters.com@reuters.net))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.